tiprankstipranks
Trending News
More News >
Living Cell Technologies Ltd. (AU:1AI)
ASX:1AI

Compare Living Cell Technologies (1AI) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Living Cell Technologies
AU$0.02
AU$35.46M
-46.00
130.00%
Invex Therapeutics Ltd.
AU$0.12
AU$9.02M
-19.05
71.43%
Regeneus Ltd.
AU$0.47
AU$13.78M
-2.27
50.00%
Chimeric Therapeutics Ltd.
AU$0.01
AU$11.05M
10.00%
Neuroscientific Biopharmaceuticals Ltd.
AU$0.10
AU$51.55M
-10.71
264.86%
Memphasys Ltd
AU$0.01
AU$16.12M
-3.57
0.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:1AI
Living Cell Technologies
0.02
0.01
130.00%
AU:IXC
Invex Therapeutics Ltd.
0.12
0.05
71.43%
AU:CMB
Regeneus Ltd.
0.59
0.18
46.25%
AU:CHM
Chimeric Therapeutics Ltd.
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.14
0.10
237.50%
AU:MEM
Memphasys Ltd
0.01
0.00
0.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts